No abstract available
Keywords:
JAK1 and JAK2 inhibitors; biomarkers; immune checkpoint inhibitor (ICI); immunotherapy; irAE.
MeSH terms
-
Autoimmune Diseases* / etiology
-
Humans
-
Neoplasms* / therapy
Grants and funding
The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.